




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery and Heart Failure</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=c5ff91a9-f0f4-4291-84b8-6604ce7c4778</link>
        <description>Clinical Topic Feed: Cardiac Surgery and Heart Failure</description>
        <language>en</language>

        

                <item>
                    <title>Online Exclusive | From the Member Sections | Integrating Palliative Care Into LVAD Care</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/01/Online-Exclusive-Integrating-Palliative-Care-Into-LVAD-Care</link>                    <description>Caring for a person with a left ventricular assist device (LVAD) teaches the importance of shared decision-making and the complexities of care through the end of life. Clinicians carry those memories, such as a young mother living with an LVAD and recurrent driveline infections...</description>
                    <pubdate>1794229380000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: SPECIAL TCT RECAP focusing on four studies: PROGRESS on TAVR &amp; AS; SIMPLAFFY on NOACS &amp; DAPT; SPYRAL AFFIRM on RDN &amp; BP; IRIS MAIN on PCI &amp; CABG </title>
<link>/Latest-in-Cardiology/Articles/2026/11/05/17/14/eagles-eye-view-05nov2026</link>                    <description>In this special edition of the View, Dr. Eagle&#226;€&#175;looks at four studies presented at the recent TCT Conference that could have immediate effects on your practice.</description>
                    <pubdate>1793899080000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ENCIRCLE: Two-Year Results Following Transeptal TMVR in Patients With Severe MR</title>
<link>/Latest-in-Cardiology/Articles/2026/11/02/22/45/tues-356pm-jacc-combo-tct-2026</link>                    <description>Patients with symptomatic mitral regurgitation (MR) who underwent full percutaneous transseptal transcatheter mitral valve replacement (TMVR) with the SAPIEN M3 system continued to see durable near MR elimination and sustained improvements in functional and health status outcomes at two years...</description>
                    <pubdate>1793740500000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>CLASP II TR: TTVr With PASCAL System Improves Health Status in Patients With Symptomatic Severe TR</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/00/11/mon-125pm-clasp-tct-2026</link>                    <description>Among patients with symptomatic severe tricuspid regurgitation (TR), transcatheter tricuspid valve repair (TTVr) with the PASCAL system in addition to optimal medical therapy (OMT) showed significant improvement in health status at one year when compared to OMT alone and no significant difference in mortality or heart failure (HF) hospitalization...</description>
                    <pubdate>1793643900000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PROGRESS: TAVR Superior to Clinical Surveillance in Patients With Moderate AS With At-Risk Features</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/00/11/mon-1240pm-progress-tct-2026</link>                    <description>In patients with moderate aortic stenosis (AS) and at least one at-risk feature, earlier TAVR lowered the incidence of death or heart failure (HF) event, reduced HF hospitalizations and improved quality of life at two years compared to clinical surveillance, according to findings from the PROGRESS trial presented at TCT 2026 and simultaneously published in NEJM.</description>
                    <pubdate>1793641200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Cost-Effectiveness of Early TAVR; TR and Mortality; Superiority of Tricuspid Repair</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/00/11/sun-627pm-combo3-tct-2026</link>                    <description>New late-breaking research presented at TCT 2026 highlights the cost-effectiveness of early TAVR in asymptomatic severe aortic stenosis (AS), the association between increasing tricuspid regurgitation (TR) severity and mortality, and the benefits of transcatheter tricuspid valve repair.</description>
                    <pubdate>1793577180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Highlight Challenging Cases From TCT 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/10/26/16/55/sat-challenging-cases-tct-2026</link>                    <description>New challenging cases presented at TCT 2026 and simultaneously published across the JACC family of journals offer insights into key questions and challenging scenarios in interventional cardiology.</description>
                    <pubdate>1793558940000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>RELIEVE-HF Analysis: Interatrial Shunt Safety Outcomes Differ By HF Phenotype</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/27/15/01/RELIEVE-HF</link>                    <description>Interatrial shunt implantation was mechanically reliable and durable through two years in patients with symptomatic heart failure (HF), with safety outcomes differing by phenotype, according to findings published Oct. 20 in JACC: Heart Failure.</description>
                    <pubdate>1793126040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>HFSA 2026: ATTRibute-CM Analysis; LINK-HF2 Results; More</title>
<link>/Latest-in-Cardiology/Articles/2026/10/19/18/12/HFSA-2026</link>                    <description>New science presented at HFSA 2026 and simultaneously published in JACC: Heart Failure spans several evolving areas in heart failure (HF), from ATTR-CM biomarkers and measures of physical function to predictors of adverse outcomes in transplant recipients to artificial intelligence (AI) wearables enhancing discharge care following HF hospitalization.</description>
                    <pubdate>1792523820000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Racial, Ethnic and Place-Based Disparities in CVD Mortality in the US</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/05/20/22/Racial-Ethnic-and-Place-Based-Disparities-in-CVD-Mortality</link>                    <description>Despite sustained declines in overall cardiovascular disease mortality in the U.S., racial, ethnic and place-based disparities persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in JACC.</description>
                    <pubdate>1791383400000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>